|
|
Volumn 51, Issue 2, 2009, Pages 79-81
|
|
New drug discovery for Alzheimer's disease: Challenges and hopes
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA SYNUCLEIN;
AMYLOID BETA PROTEIN;
AMYLOID BETA PROTEIN[1-40];
AMYLOID BETA PROTEIN[1-42];
AMYLOID PRECURSOR PROTEIN;
BETA SECRETASE;
BIOLOGICAL MARKER;
CURCUMIN;
DOUBLE STRANDED RNA;
FRAGILE X MENTAL RETARDATION PROTEIN;
GAMMA SECRETASE;
MESSENGER RNA;
ALZHEIMER DISEASE;
ANTIINFLAMMATORY ACTIVITY;
ANTIOXIDANT ACTIVITY;
ANTISENSE THERAPY;
BLOOD BRAIN BARRIER;
BRAIN DISEASE;
BRAIN METABOLISM;
BRAIN TISSUE;
CARBOXY TERMINAL SEQUENCE;
CEREBROSPINAL FLUID;
CLINICAL TRIAL;
COGNITION;
DAILY LIFE ACTIVITY;
DEMENTIA;
DISEASE COURSE;
DISEASE SEVERITY;
DRUG DELIVERY SYSTEM;
DRUG DESIGN;
DRUG RESEARCH;
DRUG TARGETING;
ECONOMIC ASPECT;
EDITORIAL;
ENZYME ACTIVITY;
EXPERIMENTAL MODEL;
FRAGILE X SYNDROME;
HEPATITIS C;
HUMAN;
INTERNEURON;
MEDICAL RESEARCH;
MENTAL DETERIORATION;
NERVE CELL NECROSIS;
NERVE DEGENERATION;
NEUROFIBRILLARY TANGLE;
NEUROPATHOLOGY;
NONHUMAN;
OXIDATION REDUCTION REACTION;
PATHOLOGY;
PATHOPHYSIOLOGY;
PROTEIN AGGREGATION;
PROTEIN PROCESSING;
QUALITY OF LIFE;
RETINA MACULA AGE RELATED DEGENERATION;
RNA INTERFERENCE;
SENILE PLAQUE;
SIGNAL TRANSDUCTION;
SOCIAL STATUS;
TRANSGENIC MOUSE;
UNITED STATES;
VIRUS INFECTION;
|
|
EID: 77953466484
PISSN: 00195545
EISSN: 19983794
Source Type: Journal
DOI: 10.4103/0019-5545.49444 Document Type: Editorial |
|
Times cited : (3)
|
|
References (10)
|
